Cascading Attrition of In Vivo CAR-T Therapy: From Systemic Delivery Failure to Functional Collapse

Critical Reviews in Oncology/Hematology · Published 2026-08-01 · DOI 10.1016/j.critrevonc.2026.105521

Authors (4)

Haipeng Rao, Shichu Xu, Jiannan Chen, Zhigang Guo

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Rao, H., Xu, S., Chen, J., et al. (2026). Cascading Attrition of In Vivo CAR-T Therapy: From Systemic Delivery Failure to Functional Collapse. Critical Reviews in Oncology/Hematology. https://doi.org/10.1016/j.critrevonc.2026.105521

Related articles

• In vivo engineering of CAR-T cells: delivery strategies and clinical translation · Biomarker Research · 2026 · Cites or is cited by this article
• In vivo CAR cell therapy: from bench to bedside · Journal of Hematology & Oncology · 2025 · Cites or is cited by this article
• From Ex Vivo to In Vivo : Advances in Lentiviral Vector Engineering for CAR-T Therapy · Immune Network · 2026 · Cites or is cited by this article
• Tonic signaling in CAR-T therapy: the lever long enough to move the planet · Frontiers of Medicine · 2025 · Cites or is cited by this article
• In vivo CAR-T cell engineering: concept, research progress, potential challenges and enhancement strategies · Experimental Hematology & Oncology · 2025 · Cites or is cited by this article
• TROP-2 in solid tumors: From oncogenic driver to therapeutic target with antibody-drug conjugates · Critical Reviews in Oncology/Hematology · 2026 · Same journal
• Circulating tumour DNA and molecular residual disease in oesophageal cancer: Clinical readiness, evidence gaps and trial-ready applications · Critical Reviews in Oncology/Hematology · 2026 · Same journal
• Molecular mechanisms of targeted therapy in breast cancer: An integrated signaling network perspective · Critical Reviews in Oncology/Hematology · 2026 · Same journal
• The adipose microenvironment in colorectal cancer: Navigating the nexus of inflammation, metabolism, and metastatic reprogramming · Critical Reviews in Oncology/Hematology · 2026 · Same journal
• Biomimetic nanoparticles for metastatic breast cancer: Advancing targeted drug delivery beyond conventional nanomedicine · Critical Reviews in Oncology/Hematology · 2026 · Same journal